Find Paid Clinical Trials in Illinois

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Illinois

Top of Directory » All Locations » United States » Illinois




  • Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center

    Conditions:   Chronic Kidney Disease;   Glomerulopathy
    Intervention:  
    Sponsors:   University of Michigan;   St. John's Health System;   University of Illinois;   Wayne State University
    Recruiting - verified November 2009

  • Reinforcing Therapist Performance

    Condition:   Implementation of Evidence-based Treatment
    Intervention:   Behavioral: Incentive Condition
    Sponsors:   Chestnut Health Systems;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified November 2009

  • Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population

    Conditions:   Atopic Dermatitis;   Ichthyosis Vulgaris
    Intervention:  
    Sponsors:   Northwestern University;   IBT laboratories
    Not yet recruiting - verified November 2009

  • Clinical Evaluation of a Silicone Hydrogel Lens

    Condition:   Lotrafilcon A Contact Lens Use
    Intervention:  
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks

    Condition:   Angioid Streaks
    Intervention:   Drug: ranibizumab
    Sponsors:   University of Illinois;   Genentech
    Not yet recruiting - verified November 2009

  • A Study With RO4917523 in Patients With Fragile X Syndrome

    Condition:   Fragile X Syndrome
    Interventions:   Drug: RO4917523;   Drug: Placebo;   Drug: RO4917523;   Drug: Placebo
    Sponsor:   Hoffmann-La Roche
    Not yet recruiting - verified November 2009

  • Nephrogenic Systemic Fibrosis (NSF): A Chart Review With Analysis of Tissue Gadolinium Levels

    Conditions:   Nephrogenic Systemic Fibrosis;   Nephrogenic Fibrosing Dermopathy
    Intervention:  
    Sponsors:   Northwestern University;   National Institutes of Health (NIH)
    Recruiting - verified November 2009

  • Erlotinib Hydrochloride in Treating Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Precancerous Lesions of the Lung

    Conditions:   Cancer Survivor;   Esophageal Cancer;   Head and Neck Cancer;   Lung Cancer;   Precancerous/Nonmalignant Condition
    Interventions:   Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies;   Other: pharmacological study
    Sponsors:   Robert H. Lurie Cancer Center;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Intraoperative Bleeding During Endoscopic Sinus Surgery

    Condition:   Blood Loss
    Interventions:   Drug: propofol;   Drug: sevoflurane
    Sponsor:   University of Chicago
    Not yet recruiting - verified November 2009

  • AZD6244 in Treating Patients With Recurrent or Persistent Endometrial Cancer

    Condition:   Endometrial Cancer
    Interventions:   Drug: MEK inhibitor AZD6244;   Other: laboratory biomarker analysis
    Sponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Phase IIb 78-week Study in Patients on a Basal Insulin +/- Metformin and/or Sulfonylurea and Are Not at Goal to Add BI 10773 vs. Placebo

    Condition:   Diabetes Mellitus, Type 2
    Intervention:   Drug: BI 10773
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • Staging of Axillary Lymph Nodes Using the PEM Flex Solo II Pet Scanner in Patients With Breast Cancer

    Condition:   Breast Cancer
    Intervention:   Device: Positron Emission Mammography
    Sponsor:   University of Chicago
    Recruiting - verified November 2009

  • Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer

    Condition:   Lung Cancer, Stage IIIb or IV
    Intervention:   Other: CHESS website for lung cancer patient + internet access if needed
    Sponsors:   University of Wisconsin, Madison;   Harry Gray Cancer Center Hartford Hospial;   M.D. Anderson Cancer Center;   University of Illinois;   University of Wisconsin Carbone Cancer Center
    Not yet recruiting - verified November 2009

  • Retinal Function in Parkinson's Disease

    Condition:   Parkinson's Disease
    Intervention:  
    Sponsor:   Department of Veterans Affairs
    Recruiting - verified November 2009

  • Reducing Dynamic Hyperinflation Through Breathing Retraining

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Other: breathing retraining;   Other: exercise training
    Sponsor:   Department of Veterans Affairs
    Recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Study Evaluating the Efficacy and Safety of SBI-087 in Seropositive Subjects With Active Rheumatoid Arthritis

    Condition:   Active Rheumatoid Arthritis
    Intervention:   Drug: SBI-087
    Sponsor:   Wyeth
    Recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • Effect of Veramyst and Olopadatine 0.2% Opthalmic Solution on Allergy Symptoms

    Condition:   Seasonal Allergic Rhinitis
    Interventions:   Drug: Veramyst /Artificial tears;   Drug: Veramyst / Artificial tears lubricant eye drops;   Drug: Veramyst nasal spray and Olopatadine eye drops;   Other: Veramyst placebo and Olopatadine0.2% eye drops
    Sponsors:   University of Chicago;   GlaxoSmithKline
    Recruiting - verified November 2009

  • Vitamin D for Chronic Sinusitis

    Condition:   Chronic Sinusitis
    Interventions:   Dietary Supplement: vitamin D placebo;   Dietary Supplement: Vitamin D
    Sponsor:   University of Chicago
    Recruiting - verified November 2009

  • Study of A3309 in Patients With Chronic Idiopathic Constipation

    Conditions:   Constipation;   Chronic Constipation
    Intervention:   Drug: A3309
    Sponsor:   Albireo
    Recruiting - verified November 2009

  • Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma

    Condition:   Hepatocellular Carcinoma
    Intervention:   Drug: sorafenib with temsirolimus
    Sponsors:   University of California, San Francisco;   Northwestern University
    Not yet recruiting - verified November 2009

  • RSP® Prospective Multi-Center Study

    Conditions:   Rotator Cuff Deficiency;   Shoulder Arthropathy;   Failed Shoulder Replacement
    Intervention:   Device: Encore Reverse Shoulder Prosthesis (RSP®)
    Sponsor:   Encore Medical, L.P.
    Not yet recruiting - verified October 2009

  • Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

    Condition:   Leukemia
    Interventions:   Genetic: DNA analysis;   Genetic: Southern blotting;   Genetic: cytogenetic analysis;   Genetic: polymerase chain reaction
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720

    Condition:   Leukemia
    Intervention:   Other: laboratory biomarker analysis
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of Tissue and Blood Samples From Patients With High-Grade Glioma

    Condition:   Brain and Central Nervous System Tumors
    Interventions:   Genetic: DNA ploidy analysis;   Genetic: fluorescence in situ hybridization;   Genetic: microsatellite instability analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Other: diagnostic laboratory biomarker analysis;   Other: flow cytometry;   Other: immunohistochemistry staining method
    Sponsors:   North Central Cancer Treatment Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Erlotinib for Treatment of Psoriasis

    Condition:   Psoriasis
    Interventions:   Drug: erlotinib;   Other: placebo tablet
    Sponsors:   Northwestern University;   OSI Pharmaceuticals
    Not yet recruiting - verified October 2009

  • Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

    Condition:   Leukemia
    Interventions:   Genetic: fluorescence in situ hybridization;   Genetic: mutation analysis;   Genetic: nucleic acid sequencing;   Genetic: polymerase chain reaction;   Genetic: western blotting;   Other: flow cytometry;   Other: laboratory biomarker analysis
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy

    Conditions:   Excessive Daytime Sleepiness;   Narcolepsy
    Interventions:   Drug: Placebo;   Drug: PF-03654746
    Sponsor:   Pfizer
    Recruiting - verified November 2009

  • Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis

    Condition:   Ulcerative Colitis
    Interventions:   Drug: Asacol (mesalamine), High Dose;   Drug: Asacol (mesalamine), Low Dose
    Sponsor:   Procter and Gamble
    Recruiting - verified October 2009

  • The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease

    Condition:   Metabolic Bone Disease
    Interventions:   Drug: Lanthanum Carbonate;   Drug: Fosrenol;   Drug: placebo
    Sponsors:   NorthShore University HealthSystem Research Institute;   Shire Pharmaceutical Development
    Not yet recruiting - verified October 2009

  • Computer-Based Alcohol Use Disorder Recovery System

    Condition:   Alcohol Dependence
    Intervention:   Behavioral: Addiction CHESS
    Sponsors:   University of Wisconsin, Madison;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting - verified October 2009

  • Effect of Prednisone onTregs and TH17

    Condition:   Chronic Rhinosinusitis
    Intervention:   Drug: prednisone
    Sponsor:   University of Chicago
    Recruiting - verified November 2009

  • Gene Therapy for the Treatment of Chronic Stable Angina

    Condition:   Myocardial Ischemia
    Intervention:   Genetic: VM202
    Sponsor:   ViroMed Co., Ltd.
    Not yet recruiting - verified October 2009

  • Beta-Blockers in Heart Failure: Pharmacy-level Intervention Comparison

    Condition:   Heart Failure
    Interventions:   Other: Level 1 (Provide site-specific information);   Other: Level 2 (Provide site- and patient-specific information)
    Sponsor:   Department of Veterans Affairs
    Recruiting - verified October 2009

  • Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

    Condition:   Lymphoma
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

    Conditions:   Lymphoma;   Lymphoproliferative Disorder
    Interventions:   Other: biologic sample preservation procedure;   Other: informational intervention
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

    Conditions:   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
    Interventions:   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI);   Eastern Cooperative Oncology Group
    Recruiting - verified November 2009

  • TAXUS Libertē Post Approval Study

    Condition:   Coronary Artery Disease
    Interventions:   Device: TAXUS Liberté Paclitaxel-Eluting Coronary Stent;   Drug: prasugrel;   Drug: placebo;   Drug: aspirin
    Sponsors:   Boston Scientific Corporation;   Eli Lilly and Company;   Daiichi Sankyo Inc.
    Not yet recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

    Condition:   Pregnancy Prevention
    Intervention:   Drug: DR-103
    Sponsor:   Teva Women's Health
    Recruiting - verified October 2009

  • Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients

    Condition:   Type II Diabetes Mellitus
    Interventions:   Drug: JTT-654;   Drug: JTT-654 Placebo
    Sponsor:   Akros Pharma Inc.
    Recruiting - verified November 2009

  • Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence

    Condition:   Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency
    Intervention:   Device: Coaptite®
    Sponsor:   BioForm Medical, Inc.
    Recruiting - verified November 2009

  • Safety and Efficacy of AIN457 in Behçet's Patients With Posterior or Panuveitis

    Condition:   Behcet Disease
    Interventions:   Biological: AIN457;   Biological: AIN457;   Biological: Placebo
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified November 2009

  • Safety and Tolerability of TAK-491 Plus Chlorthalidone Compared to Olmesartan Medoxomil-Hydrochlorothiazide in Subjects With Essential Hypertension

    Condition:   Essential Hypertension
    Interventions:   Drug: TAK-491 and chlorthalidone;   Drug: Olmesartan medoxomil-hydrochlorothiazide
    Sponsor:   Takeda Global Research & Development Center, Inc.
    Recruiting - verified November 2009

  • The Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis to Assess the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

    Condition:   Rheumatoid Arthritis
    Interventions:   Biological: Placebo;   Biological: Certolizumab pegol
    Sponsor:   UCB, Inc.
    Recruiting - verified November 2009

  • Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth

    Conditions:   HIV Infections;   H1N1 Influenza Virus
    Intervention:   Biological: Influenza A (H1N1) 2009 monovalent vaccine
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Not yet recruiting - verified October 2009

  • Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia

    Condition:   Craniotomy
    Intervention:   Drug: Insulin
    Sponsor:   Northwestern University
    Recruiting - verified November 2009

  • Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1

    Conditions:   HIV-1 Infection;   HIV Infections
    Interventions:   Drug: maraviroc;   Drug: darunavir;   Drug: ritonavir
    Sponsors:   Northwestern University;   Pfizer;   Tibotec, Inc
    Not yet recruiting - verified October 2009

  • Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

    Conditions:   HIV Infections;   H1N1 Influenza Virus
    Intervention:   Biological: Influenza A (H1N1) monovalent vaccine
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials